Grants and Contributions:
Title:
Advanced Remote Multi-Disease Management
Agreement Number:
1033970
Agreement Value:
$200,000.00
Agreement Date:
Aug 17, 2025 - May 31, 2026
Description:
The project will implement advanced capabilities to the Vitall Intelligence platform to enable practitioners to remotely manage diseases within their patient cohort thereby enabling them to provide better care, reduce comorbidities, and prevent hospital visits and stays.
In order to deliver this service to practitioners, VITALL will scale the platform by adding disease specific features, AI tools for data insights, in-app communication, enhanced data collection, as well as provision client data jurisdiction requirements.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Uxbridge, Ontario, CA L9P 1H6
Reference Number:
172-2025-2026-Q2-1033970
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
718859713
Recipient Type:
For-profit organization
Recipient's Operating Name:
VITALL
Recipient's Legal Name:
Vitall Intelligence Inc.
Federal Riding Name:
Pickering--Uxbridge
Federal Riding Number:
35085
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211